This website is intended for healthcare professionals

News

Examining prescribing in children and adolescents

This cohort study, published in The Lancet Psychiatry journal, aimed to identify trends in antipsychotic drug prescribing to children and adolescents in England (Radojčić et al, 2023). This was driven...

Research to support diabetes remission in general practice

Diabetes UK (2023), together with the American Diabetes Association and the European Association for the Study of Diabetes, defines remission as HbA1c levels remaining below 48 mmol/mol or 6.5% for...

Prescribing during pregnancy

This article was published in BMC Medicine, used a retrospective cohort study approach to examine data between 2000 and 2019 (Subramanian et al, 2023). The author's main driver to conduct this...

Past the peak: navigating depression in the aftermath of COVID-19

Depression was already one of the commonest mental disorders in Great Britain, but new research has shown that the COVID-19 pandemic has resulted in an increase of mental distress in adults across the...

Cardiac effects of cancer therapy and what is being done about it

The drug doxorubicin slows or stops the spread of cancer cells by blocking the enzyme, topoisomerase, which cancer cells rely on for their division and growth (Cancer Research UK (CRUK), 2019). It is...

Long-term effects of COVID-19: impact on prescribing practice

This article provides follow-up guidance on patients with the most severe COVID-19 disease, namely, those that required critical care or had changes noted on chest x-ray consistent with COVID-19...

Antibiotic awareness and preventing further antimicrobial resistance

The development of antibiotics has been revolutionary for medicine and public health. However, given the resistance that is now building up against them, we are facing one of the most significant and...

Novel research into glucose-lowering drugs for heart failure shows promise

Alongside important lifestyle changes, first-line treatment for heart failure is an angiotensin-converting enzyme (ACE) inhibitor and a beta blocker licensed for heart failure in people with reduced...

Research Roundup

Asystematic review published in 2018 synthesised evidence from 42 papers and highlighted the facilitators and barriers to nurse and pharmacist independent prescribing (Graham-Clarke et al, 2018). An...

Dependence and withdrawal: how to better support patients

The PHE (2019) review was a response to a call from the Minister for public health and primary care in 2017 for PHE to identify the scale, distribution and causes of prescription drug dependence, and...

Medical cannabis: prescribing and research developments

The recently published study in the Journal of Psychopharmacology has revealed that although cannabis does have some harmful effects on the areas of the brain involved in processing sensory and...

Why choose Journal of Prescribing Practice?

Journal of Prescribing Practice shares the latest clinical expertise and professional guidance for non-medical prescribers. Our goal is to provide the knowledge to help you prescribe more efficiently and effectively.

What's included

  • Evidence-based best practice

  • Drug updates

  • Pharmacology information

  • Calculation skills

Subscriptions start:

From £16.25 GBP